Acquisition Advantage Leverage Cure Medical's acquisition by ConvaTec in 2021 to access consolidated Continence Care distribution networks, procurement contracts, and cross-sell opportunities across hospitals, clinics, and long-term care providers. The portfolio spans men, women, and children with innovative options like Cure Dextra Closed System and hydrophilic catheters, enabling entry into multi-channel channels and higher value deals.

Diverse User Focus The product lineup addresses a broad user base, including men, women, and pediatric users, and includes solutions for limited hand dexterity such as the Cure Dextra Closed System. This positions the company to target pediatric departments, women's health providers, and home care agencies seeking versatile, user-friendly catheter solutions.

Advocacy Partnerships Past collaboration with The Rollettes Experience demonstrates a track record of partnering with disability and advocacy communities, offering a pathway to co-branding, education campaigns, and targeted deployments in clinics and care settings that serve wheelchair users and other mobility-impaired patients.

Innovative Portfolio The portfolio includes multiple high-demand formats such as closed systems, hydrophilic catheters, and extended-length options like 16-inch hydrophilic catheters, enabling upsell opportunities to hospitals and long-term care facilities seeking infection risk reduction, convenience, and improved patient comfort.

Growth Readiness With a revenue range of zero to one million and a lean team, Cure Medical can act as a nimble partner for pilots with distributors and direct care providers, leveraging existing marketing tech and ConvaTec synergies to scale via DME networks, regional distributors, and care facilities.